IDEX Investing Cash Flow decreased by 15.9% to -$20.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 104.0%, from -$10.00M to -$20.40M. Over 3 years (FY 2021 to FY 2025), Investing Cash Flow shows an upward trend with a -41.8% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$489.80M | -$14.90M | -$73.90M | -$124.40M | -$135.70M | $0.00 | -$692.80M | -$29.20M | -$147.40M | -$193.80M | -$20.00M | $31.70M | -$1.00B | -$14.70M | -$10.00M | -$14.50M | -$95.50M | -$17.60M | -$20.40M |
| QoQ Change | — | +97.0% | -396.0% | -68.3% | -9.1% | +100.0% | — | +95.8% | -404.8% | -31.5% | +89.7% | +258.5% | <-999% | +98.5% | +32.0% | -45.0% | -558.6% | +81.6% | -15.9% |
| YoY Change | — | — | — | — | +72.3% | +100.0% | -837.5% | +76.5% | -8.6% | +72.0% | +31.5% | +121.5% | — | +92.4% | +50.0% | -145.7% | +90.5% | -19.7% | -104.0% |